These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 30060202)
1. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma. Zhao R; Yu X; Feng Y; Wang J; Mao Y; Yin W; Zhang Z; Guo X; Ma S Jpn J Clin Oncol; 2018 Sep; 48(9):799-805. PubMed ID: 30060202 [TBL] [Abstract][Full Text] [Related]
2. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk. Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916 [TBL] [Abstract][Full Text] [Related]
3. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan. Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407 [TBL] [Abstract][Full Text] [Related]
4. Surveillance Imaging Patterns and Outcomes Following Radiation Therapy and Radical Resection for Localized Extremity and Trunk Soft Tissue Sarcoma. Patel SA; Royce TJ; Barysauskas CM; Thornton KA; Raut CP; Baldini EH Ann Surg Oncol; 2017 Jun; 24(6):1588-1595. PubMed ID: 28058559 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery. Zhao RP; Yu XL; Zhang Z; Jia LJ; Feng Y; Yang ZZ; Chen XX; Wang J; Ma SL; Guo XM Radiat Oncol; 2016 Feb; 11():25. PubMed ID: 26911328 [TBL] [Abstract][Full Text] [Related]
9. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400 [TBL] [Abstract][Full Text] [Related]
10. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study. Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792 [TBL] [Abstract][Full Text] [Related]
11. Predictors of survival and recurrence in primary leiomyosarcoma. Gladdy RA; Qin LX; Moraco N; Agaram NP; Brennan MF; Singer S Ann Surg Oncol; 2013 Jun; 20(6):1851-7. PubMed ID: 23354568 [TBL] [Abstract][Full Text] [Related]
12. High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma. Traweek RS; Lyu HG; Witt RG; Snyder RA; Nassif EF; Krijgh DD; Smith JM; Tilney GS; Feng C; Chiang YJ; Torres KE; Roubaud MJ; Scally CP; Hunt KK; Keung EZ; Mericli AF; Roland CL Ann Surg Oncol; 2024 Jun; 31(6):4138-4147. PubMed ID: 38396039 [TBL] [Abstract][Full Text] [Related]
13. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of Postoperative Radiotherapy Using Modern Techniques in Patients with Retroperitoneal Soft Tissue Sarcoma. Kim HJ; Koom WS; Cho J; Kim HS; Suh CO Yonsei Med J; 2018 Nov; 59(9):1049-1056. PubMed ID: 30328319 [TBL] [Abstract][Full Text] [Related]
15. Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center. Montero A; Chen-Zhao X; Ciérvide R; Álvarez B; Prado A; López M; Sánchez E; Hernando O; de la Casa MA; García-Aranda M; Valero J; Alonso R; Fernández-Letón P; Rubio C Clin Transl Oncol; 2024 Jan; 26(1):204-213. PubMed ID: 37277526 [TBL] [Abstract][Full Text] [Related]
16. Survival in primary soft tissue sarcoma of the extremities and trunk. Peiper M; Zurakowski D; Zornig C Langenbecks Arch Chir; 1997; 382(4):203-8. PubMed ID: 9396000 [TBL] [Abstract][Full Text] [Related]
17. Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. Radaelli S; Fiore M; Colombo C; Ford S; Palassini E; Sanfilippo R; Stacchiotti S; Sangalli C; Morosi C; Casali PG; Gronchi A Surg Oncol; 2016 Sep; 25(3):125-31. PubMed ID: 27566012 [TBL] [Abstract][Full Text] [Related]
18. Local recurrence is correlated with decreased overall survival in patients with intermediate high-grade localized primary soft tissue sarcoma of extremity and abdominothoracic wall. Zhao R; Yu X; Feng Y; Yang Z; Chen X; Wand J; Ma S; Zhang Z; Guo X Asia Pac J Clin Oncol; 2018 Apr; 14(2):e109-e115. PubMed ID: 29071781 [TBL] [Abstract][Full Text] [Related]
19. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities. Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres. Smolle MA; van de Sande M; Hayes A; Bergovec M; Smith HG; Liegl-Atzwanger B; Tunn PU; Niethard M; Windhager R; Szkandera J; Leithner A Eur J Surg Oncol; 2021 Aug; 47(8):2182-2188. PubMed ID: 33865657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]